H0RSHOLM, Denmark--(BUSINESS WIRE)--LifeCycle Pharma A/S (OMX: LCP) today announced that LCP has received a notice that Novo A/S has increased their holdings of LCP shares from 4,096,416 to 11,628,269 shares, corresponding to 20.73 % of the shares in LCP.
